Bronchial carcinoids are derived from enterochromaffin cells within the lung," and enterochromaffin cells are APUD cells." Thus tumors derived from these cells are apudomas.
Lung scar carcinoma (LSC) was first described in 1939 by Friedrich as a form of lung cancer that originates from peripheral scars in the lung. These, in turn, may arise from infection, injury, intrinsic pulmonary disease, or recurrent episodes of tumor necrosis and healing.
The most common etiologic factor for the development of LSC is scarring secondary to tuberculosis, but it is also known to occur in the setting of pneumonia, pulmonary abscess, bronchiectasis, and pulmonary infarction.
LSC is most commonly subpleural adenocarcinoma with no evidence of bronchial origin and is characterized histologically by contiguity with dense, hyalinized scar tissue that itself does not comprise any tumor cells.
Bronchiectasis cannot cause malignancy.
The complications which may be associated with bronchiectasis are: Cor pulmonale, metastatic brain abscesses, and amyloidosis.
To be considered bronchiectasis, the dilation should be permanent; reversible bronchial dilation often accompanies viral and bacterial pneumonia.
Bronchiectasis is a long-term condition where the airways of the lungs become widened, leading to a build-up of excess mucus that can make the lungs more vulnerable to infection. The most common symptoms of bronchiectasis include: a persistent cough that usually brings up phlegm (sputum) shortness of breath.
WhatsApp us